Skip to main content
Clinical Trials/KCT0008873
KCT0008873
Completed
未知

Comparison of dexmedetomidine and remimazolam in conscious sedation for percutaneous thermal ablation of liver tumor: a randomized controlled study

Samsung Medical Center0 sites90 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Samsung Medical Center
Enrollment
90
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 16, 2024
Last Updated
last year
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • conscious sedation for percutaneous thermal ablation of liver tumor
  • ASA class I \- III

Exclusion Criteria

  • 1\) contraindicated for benzodiazepine\-class medication administration (e.g., patients with a known allergy to the drug or a history of hypersensitivity reactions).
  • 2\) the patient refuses

Outcomes

Primary Outcomes

Not specified

Similar Trials